Update from our HRB-CICER team

Pictured at the launch by the Minister for Health, Simon Harris, on 25 June of a new guideline from the National Clinical Effectiveness Committee (NCEC) aimed at improving the quality and safety of treating Type 1 diabetes, were: Dr Kevin Moore, Chair of the Guideline Development Group; Paul Carty from our HRB-CICER team; Professor Sean Dinneen (National Clinical Lead for Diabetes); and Niamh Smyth, Programme Manager for National Clinical Programme for Diabetes.
Pictured at the launch by the Minister for Health, Simon Harris, on 25 June of a new guideline from the National Clinical Effectiveness Committee aimed at improving the quality and safety of treating Type 1 diabetes, were: Dr Kevin Moore, Chair of the Guideline Development Group; Paul Carty from our HRB-CICER team; Professor Sean Dinneen, National Clinical Lead for Diabetes; and Niamh Smyth, Programme Manager for National Clinical Programme for Diabetes.

 

In 2017, the Health Research Board (HRB) commenced funding of the Collaboration in Ireland for Clinical Effectiveness Reviews (HRB-CICER) to support the work of the National Clinical Effectiveness Committee.

Based in HIQA, the role of the HRB-CICER team is to independently review evidence and provide scientific support for the development of national clinical guidelines and national clinical audits by guideline development groups and audit governance committees, respectively.

Type 1 diabetes 

A National Clinical Guideline on adult type 1 diabetes mellitus was launched by the Minister for Health on Monday 25 June 2018.

The National Clinical Effectiveness Committee (NCEC) requires inclusion of evidence on both the clinical- and cost-effectiveness of health technologies and the estimation of a budget impact analysis in the development of all National Clinical Guidelines in Ireland.

To support the development of the national clinical guideline, HRB-CICER conducted a review of economic evidence (to ensure that the guideline was informed by evidence of cost-effectiveness) and a budget impact analysis (to estimate the financial implications of the guideline). It was identified that three key changes to service delivery will occur as a result of implementation of the guideline recommendations. These are:

  • the national provision of a high-quality structured patient education programme to empower people with Type 1 diabetes to effectively manage their diabetes and the external factors that can influence their blood glucose levels such as exercise and stress
  • the standardisation of patient follow-up in diabetes clinics where patients are recalled at least every six months
  • short courses for all staff who deliver care to people with Type 1 diabetes in Ireland.

Both HRB-CICER reports supporting the National Clinical Guideline on adult type 1 diabetes mellitus have been published on the NCEC website.